Scrambler Therapy for Post-Stroke Pain
1 other identifier
interventional
100
1 country
1
Brief Summary
The Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2022
CompletedFirst Posted
Study publicly available on registry
October 3, 2022
CompletedStudy Start
First participant enrolled
May 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
January 26, 2026
January 1, 2026
4.6 years
September 28, 2022
January 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction in post stroke pain
At least a 50% reduction in post stroke pain
6 months
Study Arms (1)
Scrambler Therapy
ACTIVE COMPARATORUsing Scrambler Therapy for Post Stroke Pain all participants will either undergo either 5 or 10 treatments using Scrambler Therapy. The number of treatments will be decided by a randomization process.
Interventions
All participants will either undergo either 5 or 10 treatments using Scrambler Therapy. The number of treatments will be decided by a randomization process.
Eligibility Criteria
You may qualify if:
- Men and women over the age of 18 with ischemic or hemorrhagic stroke seen on imaging and a positive finding for pain in the area(s) affected by their stroke location will be included.
- The patients must be at least one month post-stroke but can otherwise enroll at any point.
You may not qualify if:
- Patients with TIA
- Patients with no evidence of stroke on MRI
- Patients with implantable devices such as pacemakers, defibrillators, spinal cord stimulators
- Patients with history of myocardial infarction in the past 6 months
- Patients with uncontrolled epilepsy
- Patients with symptomatic brain metastases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins Bayview Hospital
Baltimore, Maryland, 21224, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Dawn Merbach, MNP
Johns Hopkins University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2022
First Posted
October 3, 2022
Study Start
May 15, 2023
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
January 26, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share